bioAffinity Launches New CyPath Lung Validation Study
at www.tipranks.com (Wed, 25-Feb 10:08 AM)
BIAF’s CyPath Lung Test Offers 92% Sensitivity, Spurs Noninvasive Shift for High-Risk Patients
Market Chameleon (Thu, 19-Feb 11:55 AM)
